A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Atossa Therapeutics Inc.’s current trading price is -38.38% away from its 52-week high, while its distance from the 52-week low is 67.60%. The stock’s price range for this time frame has been between $0.50 and $1.36. The trading volume of the company’s shares in the Healthcare reached around 3.11 million for the day, which was evidently higher than the average daily volume of 0.3 million over the last three months.
Currently, the stock price of Atossa Therapeutics Inc. (ATOS) is $0.84. In the most recent trading session, the stock underwent a significant upswing, peaking at $0.88 after opening at $0.73. The stock touched a low of $0.73 before closing at $0.73.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Atossa Therapeutics Inc.’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $1.36 on 06/09/22, and the lowest price during the same period was recorded at $0.50 on 12/30/22.
How Financial Performance Impacts Market Capitalization
Atossa Therapeutics Inc. (ATOS) has experienced a quarterly rise of 16.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 106.11M and boasts a workforce of 9 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7241, with a change in price of +0.3360. Similarly, Atossa Therapeutics Inc. recorded 446,472 in trading volume during the last 100 days, posting a change of +66.93%.
How ATOS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ATOS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
ATOS Stock Stochastic Average
The raw stochastic average for Atossa Therapeutics Inc. over the last 50 days is presently at 85.51%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 85.51%. Further, the company’s Stochastic %K and %D values for the last 20 days were 86.64% and 83.51%, respectively.
ATOS Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price increase of 58.56%. However, over the past six months, we’ve seen a weaker performance of 5.20%. The price of ATOS fallen by 24.70% over the last 30 days. And in the last five days, it has surged by 17.53%.
